Cargando…
Reporting bias in medical research - a narrative review
Reporting bias represents a major problem in the assessment of health care interventions. Several prominent cases have been described in the literature, for example, in the reporting of trials of antidepressants, Class I anti-arrhythmic drugs, and selective COX-2 inhibitors. The aim of this narrativ...
Autores principales: | McGauran, Natalie, Wieseler, Beate, Kreis, Julia, Schüler, Yvonne-Beatrice, Kölsch, Heike, Kaiser, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867979/ https://www.ncbi.nlm.nih.gov/pubmed/20388211 http://dx.doi.org/10.1186/1745-6215-11-37 |
Ejemplares similares
-
From publication bias to lost in information: why we need a central public portal for clinical trial data
por: Wieseler, Beate, et al.
Publicado: (2022) -
Centralised Full Access to Clinical Study Data Can Support Unbiased Guideline Development, Continuing Medical Education, and Patient Information
por: McGauran, Natalie, et al.
Publicado: (2021) -
Access to regulatory data from the European Medicines Agency: the times they are a-changing
por: Wieseler, Beate, et al.
Publicado: (2012) -
Impact of Inclusion of Industry Trial Results Registries as an Information Source for Systematic Reviews
por: Potthast, Regine, et al.
Publicado: (2014) -
Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports
por: Köhler, Michael, et al.
Publicado: (2015)